ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51653
-0.06%
Bitcoin
69,270.52
-0.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

AZTR

Azitra (AZTR)

Azitra Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AZTR
DateTimeSourceHeadlineSymbolCompany
04/06/202406:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
31/05/202422:00Business WireAzitra, Inc. Announces Presentation at the 2024 BIO International ConventionAMEX:AZTRAzitra Inc
25/05/202406:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AZTRAzitra Inc
17/05/202422:00Business WireAzitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual MeetingAMEX:AZTRAzitra Inc
10/05/202422:00Business WireAzitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual MeetingAMEX:AZTRAzitra Inc
10/05/202407:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
10/05/202407:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
10/05/202407:00Business WireAzitra, Inc. Announces Q1 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
23/04/202406:30Business WireAzitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingAMEX:AZTRAzitra Inc
19/04/202406:15Business WireAzitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024AMEX:AZTRAzitra Inc
16/03/202407:15Business WireAzitra, Inc. Announces Full Year 2023 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
27/02/202408:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:AZTRAzitra Inc
27/02/202408:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:AZTRAzitra Inc
17/02/202408:05Business WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
16/02/202412:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
16/02/202412:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
16/02/202412:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
16/02/202408:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
15/02/202401:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
14/02/202414:09Business WireAzitra, Inc. Announces Pricing of Public OfferingAMEX:AZTRAzitra Inc
20/01/202403:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AZTRAzitra Inc
20/01/202401:19Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AZTRAzitra Inc
17/01/202401:00Business WireAzitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the USAMEX:AZTRAzitra Inc
04/01/202401:00Business WireAzitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare ConferenceAMEX:AZTRAzitra Inc
05/12/202308:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AZTRAzitra Inc
15/11/202308:30Business WireAzitra, Inc. Announces Third Quarter 2023 Financial Results and Business UpdatesAMEX:AZTRAzitra Inc
16/10/202323:00Business WireAzitra to Present at the ThinkEquity ConferenceAMEX:AZTRAzitra Inc
04/10/202307:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
04/10/202307:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
04/10/202307:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

Your Recent History

ASX
CBA
Commonwealth Bank Of Aus...
ASX
WBC
Westpac Banking
FX
AUDCAD
AUD vs CAD
NYSE
MCD
McDonalds
ASX
WES
Wesfarmers
ASX
QBE
QBE Insurance
NASDAQ
NVDA
NVIDIA
ASX
BHP
BHP
ASX
NAB
National Australia Bank
FX
EURAUD
Euro vs AUD
ASX
XFL
S&P ASX 50
ASX
WPL
Woodside Petroleum
ASX
NCM
Newcrest Mining
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved